Given Leslie's history with Genentech and Axel's current position at GSK, which company wins a bidding war here? Would you expect a Roche / Her-Vaxx deal and a PD-1 / GSK deal or would the whole platform more likely go to one company? I wonder what Paul Hopper is aiming for - MERCK? It would seem unlikely to me that GSK would win a HER-Vaxx race as Herceptin is to be trialled with HER-Vaxx and you'd expect Roche to go all out for that should it prove beneficial. How does Axel split his allegiance when that time comes?
Add to My Watchlist
What is My Watchlist?
